It's Unlikely That The CEO Of Selvita S.A. (WSE:SLV) Will See A Huge Pay Rise This Year
Jun 14
Polish (WIG) Life Sciences Industry Analysis
UpdatedJun 28, 2024
DataAggregated Company Financials
Companies5
- 7D0.5%
- 3M-3.7%
- 1Y-8.6%
- YTD0.1%
Last week, the Life Sciences industry hasn't moved much but Selvita is up 6.8% in that time. Unfortunately though, the industry is down 8.6% over the past 12 months. Earnings are forecast to be flat in the coming years.
Industry Valuation and Performance
Has the Polish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 29 Jun 2024 | zł2.5b | zł413.5m | -zł32,092,283.00 | 19.4x | -76.9x | 6x |
| Mon, 27 May 2024 | zł2.7b | zł413.5m | -zł32,092,283.00 | 20.1x | -82.6x | 6.4x |
| Wed, 24 Apr 2024 | zł2.5b | zł421.0m | -zł26,364,957.00 | 18.3x | -95.8x | 6x |
| Fri, 22 Mar 2024 | zł2.6b | zł478.9m | -zł71,866,957.00 | 47.1x | -35.5x | 5.3x |
| Sun, 18 Feb 2024 | zł2.6b | zł495.9m | -zł52,637,957.00 | 45x | -48.6x | 5.2x |
| Tue, 16 Jan 2024 | zł2.5b | zł495.2m | -zł50,454,191.00 | 46.4x | -49.4x | 5x |
| Thu, 14 Dec 2023 | zł2.6b | zł495.2m | -zł50,454,191.00 | 45x | -52.3x | 5.3x |
| Sat, 11 Nov 2023 | zł2.5b | zł511.9m | -zł35,664,342.00 | 31x | -69.1x | 4.8x |
| Mon, 09 Oct 2023 | zł2.8b | zł515.2m | -zł43,528,934.00 | 39.9x | -64x | 5.4x |
| Wed, 06 Sep 2023 | zł2.8b | zł507.8m | -zł51,598,105.00 | 42.5x | -53.7x | 5.5x |
| Fri, 04 Aug 2023 | zł2.9b | zł512.4m | -zł61,559,268.00 | 46.7x | -46.6x | 5.6x |
| Sun, 02 Jul 2023 | zł2.8b | zł512.4m | -zł61,559,268.00 | 43.1x | -44.9x | 5.4x |
| Tue, 30 May 2023 | zł2.9b | zł504.7m | -zł60,194,797.00 | 46.5x | -47.8x | 5.7x |
| Thu, 27 Apr 2023 | zł2.8b | zł505.4m | -zł64,921,034.00 | 66.8x | -42.6x | 5.5x |
| Sat, 25 Mar 2023 | zł3.0b | zł473.8m | -zł77,860,781.00 | 81x | -38.8x | 6.4x |
| Mon, 20 Feb 2023 | zł3.1b | zł473.8m | -zł77,860,781.00 | 79.5x | -39.2x | 6.4x |
| Wed, 18 Jan 2023 | zł3.1b | zł483.0m | -zł79,277,613.00 | 64.1x | -39.6x | 6.5x |
| Fri, 16 Dec 2022 | zł2.6b | zł464.9m | -zł87,637,240.00 | 58.2x | -29.2x | 5.5x |
| Sun, 13 Nov 2022 | zł2.3b | zł445.7m | -zł96,033,392.00 | 57.5x | -23.8x | 5.1x |
| Tue, 11 Oct 2022 | zł2.3b | zł443.7m | -zł83,357,892.00 | 62.1x | -27.9x | 5.2x |
| Thu, 08 Sep 2022 | zł2.1b | zł409.8m | -zł84,484,453.00 | 62.2x | -25x | 5.1x |
| Sat, 06 Aug 2022 | zł2.2b | zł417.3m | -zł76,832,012.00 | 59x | -29.2x | 5.4x |
| Mon, 04 Jul 2022 | zł1.8b | zł417.3m | -zł76,832,012.00 | 50x | -23.3x | 4.3x |
| Wed, 01 Jun 2022 | zł2.1b | zł392.6m | -zł74,127,317.00 | 50.2x | -28.7x | 5.4x |
| Fri, 29 Apr 2022 | zł2.2b | zł383.1m | -zł63,046,404.00 | 51.1x | -35.4x | 5.8x |
| Sun, 27 Mar 2022 | zł2.2b | zł327.3m | -zł66,400,347.00 | 57x | -32.8x | 6.7x |
| Tue, 22 Feb 2022 | zł2.3b | zł316.7m | -zł60,433,049.00 | 59.9x | -37.5x | 7.2x |
| Thu, 20 Jan 2022 | zł2.7b | zł310.5m | -zł60,562,303.00 | 69.2x | -44.9x | 8.8x |
| Sat, 18 Dec 2021 | zł2.6b | zł310.5m | -zł60,562,303.00 | 64.2x | -43.1x | 8.4x |
| Mon, 15 Nov 2021 | zł2.8b | zł258.6m | -zł52,302,888.00 | 44.3x | -53x | 10.7x |
| Wed, 13 Oct 2021 | zł2.6b | zł256.7m | -zł41,621,781.00 | 41.5x | -61.8x | 10x |
| Fri, 10 Sep 2021 | zł2.6b | zł222.6m | -zł34,840,889.00 | 32.1x | -74.3x | 11.6x |
| Sun, 08 Aug 2021 | zł2.6b | zł222.6m | -zł34,840,889.00 | 34.2x | -75.4x | 11.8x |
Price to Earnings Ratio
-80.1x
Current Industry PE
- Investors are relatively neutral on the Polish Life Sciences industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 6.6x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have improved over the last three years.
- Revenues for these companies have grown 23% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | 1.40% | |
| Healthcare | -0.012% | |
| Life Sciences | 0.48% | |
| Clinical Research and Equipment | 0.48% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| SLV Selvita | zł68.30 | 1.9% +zł23.9m | 0.6% | PE19.2x | |
| NNG NanoGroup | zł1.70 | 20.1% +zł5.6m | 45.3% | PB4.5x | |
| RVU Ryvu Therapeutics | zł50.20 | 0.2% +zł2.3m | -16.9% | PS15.6x |